Zidovudine/lamivudine/nevirapine fixed-dose combination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zidovudine/lamivudine/nevirapine fixed-dose combination, covering 2021-11-09 to 2021-11-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand [Phase 1, Phase 2]